Compare · FIT vs OMCL
FIT vs OMCL
Side-by-side comparison of Fitbit, Inc. (FIT) and Omnicell Inc. (OMCL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FIT and OMCL operate in Computer Manufacturing (Technology), so they compete in similar markets.
- OMCL carries a market cap of $2.09B.
- OMCL has hit the wire 6 times in the past 4 weeks while FIT has been quiet.
- OMCL has more recent analyst coverage (24 ratings vs 0 for FIT).
- Company
- Fitbit, Inc.
- Omnicell Inc.
- Price
- -
- $45.80-2.53%
- Market cap
- -
- $2.09B
- 1M return
- -
- +14.67%
- 1Y return
- -
- +70.51%
- Industry
- Computer Manufacturing
- Computer Manufacturing
- Exchange
- NYSE
- NASDAQ
- IPO
- 2015
- 2001
- News (4w)
- 0
- 6
- Recent ratings
- 0
- 24
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Latest FIT
- SEC Form POS AM filed by Fitbit, Inc.
- SEC Form POS AM filed by Fitbit, Inc.
- SEC Form EFFECT filed by Fitbit, Inc.
- Amendment: SEC Form F-1/A filed by Fitbit, Inc.
- Amendment: SEC Form F-1/A filed by Fitbit, Inc.
- Unity Appoints Matthew Bromberg as New CEO
- Investment in Wyvern Reaches $15M to Secure First 3 Hyperspectral Satellites
- SEC Form SC 13G/A filed
- SEC Form SC 13G/A filed
- SEC Form SC 13G/A filed
Latest OMCL
- CHAIRMAN, CEO Lipps Randall A sold $470,000 worth of shares (10,000 units at $47.00) as part of a pre-agreed trading plan (SEC Form 4)
- Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026
- SEC Form S-8 filed by Omnicell Inc.
- President & COO Njoku Nnamdi was granted 12,309 shares, increasing direct ownership by 8% to 167,094 units (SEC Form 4)
- Omnicell Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Nnamdi Njoku Appointed President of Omnicell
- Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business
- Director Bousa Edward Peter was granted 4,603 shares, increasing direct ownership by 26% to 22,589 units (SEC Form 4)
- Director Scott Bruce E was granted 4,627 shares, increasing direct ownership by 20% to 27,600 units (SEC Form 4)
- Director Seim Robin Gene was granted 4,845 shares, increasing direct ownership by 10% to 52,198 units (SEC Form 4)